Vapor medicine dispensing and nano-mist lung cleanser system with face adapter

ABSTRACT

A system, accompanying apparatuses and methods relating to an oral or nasal enhanced nano-mist delivery and lung cleansing system having for an object to provide a safe system and method of delivering heated, moist, flavored air into the lower TB and alveolar regions of lungs.

CROSS REFERENCE TO RELATED APPLICATION

This application is a continuation-in-part and claims the benefit of andtakes priority from U.S. patent application Ser. No. 15/422,872 filed onFeb. 2, 2017, the contents of which are herein incorporated byreference.

FIELD OF THE INVENTION

The present system relates to medical systems for delivery of drugs,medications, cleansers, heated, moist, or flavored air.

BACKGROUND OF THE INVENTION

Drug delivery refers to approaches, formulations, technologies, andsystems for transporting a pharmaceutical compound in the body as neededto safely achieve its desired therapeutic effect. It may involvescientific site-targeting within the body or facilitating systemicpharmacokinetics; in any case, drug delivery is typically concerned withboth quantity and duration of drug presence. Drug delivery is oftenapproached via a drug's chemical formulation, but it may also involvemedical devices or drug-device combination products. Drug delivery is aconcept heavily integrated with dosage form and route of administration,the latter sometimes even being considered part of the definition.Concurrent drug delivery technologies modify drug release profile,absorption, distribution and elimination for the benefit of improvingproduct efficacy and safety, as well as patient convenience andcompliance. Drug release is achieved by diffusion, degradation,swelling, and affinity-based mechanisms. Most common routes ofadministration include the preferred non-invasive perioral (through themouth), topical (skin), trans mucosal (nasal, buccal/sublingual,vaginal, ocular and rectal) and inhalation.

Many medications such as peptide and protein, antibody, vaccine andgene-based drugs may not be delivered using these routes because theyare susceptible to enzymatic degradation or cannot be sufficientlyabsorbed into the systemic circulation efficiently due to molecular sizeand charge issues. For this reason, many protein and peptide drugs haveto be delivered by injection or a nano-needle array.

For example, many immunizations are based on the delivery of proteindrugs and are often done by injection. Current efforts in the area ofdrug delivery include the development of targeted delivery in which thedrug is only active in the target area of the body (for example, incancerous tissues) and sustained release formulations in which the drugis released over a period of time in a controlled manner from aformulation. In order to achieve efficient targeted delivery, thedesigned system must avoid the host's defense mechanisms and circulateto its intended site of action. Types of sustained release formulationsinclude liposomes, drug loaded biodegradable microspheres, and drugpolymer conjugates.

Concurrently, delivery through oral means has been shown to be veryeffective, particularly in pharmaceutical aerosols which may bedelivered to the lungs through oral inhalation using such mechanisms asnebulizers, mist inhalers, metered dose inhalers and dry powderinhalers. Compared with oral inhalation, it has been found that theadministration of pharmaceutical aerosols through the nose to the lungsis advantageous in a number of situations. Delivery via the nose,directly to the lung of such substance as aerosols may improve patientcomfort and compliance if a simple cannula can be used for medicationswith long delivery times as well as those that require frequent dosing.

While a number of advantages exist for nose-to-lung delivery ofpharmaceutical aerosols, one of the major draw backs to nasal deliveryof numerous substances focuses on the fact that the nose is basicallydesign to include a very effective filtration for particles, namelycilia of the two nasal cavities.

The two nasal cavities condition the air to be received by the otherareas of the respiratory tract. Owing to the large surface area providedby the nasal conchae (also known as turbinates), the air passing throughthe nasal cavity is warmed or cooled to within 1 degree of bodytemperature. In addition, the air is humidified, and dust and otherparticulate matter is removed by vibrissae, short, thick hairs, presentin the vestibule. The entire mucosa of the nasal fossae is covered by ablanket of mucus, which lies superficial to the microscopic cilia andalso filters inspired air. The cilia of the respiratory epithelium movethe secreted mucus and particulate matter posteriorly towards thepharynx where it passes into the esophagus and is digested in thestomach. The nasal cavity also houses the sense of smell and contributesgreatly to taste sensation through its posterior communication with themouth via the choanae.

Numerous recent studies have indicated that delivery of certainapplicable substances through nasal cavities has proved moreadvantageous than through conventional oral intake methods. Thus, thedirective includes ensuring nose-to-lung delivery with streamlined nasalcannulas and condensational aerosols was highly efficient and targeteddeposition to the lower TB and alveolar regions.

SUMMARY OF THE INVENTION

The instant apparatus, system and accompanying methods, as illustratedherein, is clearly not anticipated, rendered obvious, or even present inany of the prior art mechanisms, either alone or in any combinationthereof. Therefore, it is an object of the instant invention to providevarious systems and accompanying apparatuses for oral, nasal orpropellant mist enhanced delivery and lung cleansing system andassociated apparatuses.

The present system, accompanying apparatuses and methods relate to anoral, nasal or propellant enhanced mist delivery and lung cleansingapparatuses and has for an object to provide a safe and harmless meansfor and method of delivering medication with heated, moist, flavoredair; or by inhaling warm medication like methanol into the lungs in caseof a respiratory ailment under direction of a physician.

It is an additional objective to introduce a system whereinnano-particles are generated wherein the nano-particles are of a sizeand order to not become trapped and filtered by the cilia and thuspossess an ability to reach the alveoli and lung sacs.

It is an additional objective to introduce a system wherein depositionallosses of drug dosages in the nose are eliminated through the productionand utilization of smaller than conventional sized pharmaceuticalaerosols (3-7 μm) particles.

In contrast with conventional delivery, the use of initiallysubmicrometer aerosols and condensational growth techniques haverecently been shown to provide very efficient nose-to-lung drug delivery

It is an additional objective to introduce a system utilizing Nano-Mistwhich is a concentration of extremely small measured droplets in a sizerange from 50 nano-meters to 400 nano-meters.

It is a further object to introduce a nose-to-lung delivery approachwith targeted deposition to the lower TB and alveolar regions.

It is a further object to introduce a system including a face mask whichforms an occlusive seal with an intake portion of human face in ordernot to minimize loss of nano-particles.

It is also an object to introduce a system including a face mask whichforms an occlusive seal with the area surrounding the human nose inorder not maximize intake and mimimize loss of nano-particles.

It is also an object to introduce a system including a face mask whichforms an occlusive seal with the area surrounding the human mouth inorder not maximize intake and minimize loss of nano-particles.

It is also an objective to introduce a system including a primary use oflife extension and pain management. Another object of the system is toprovide an article of manufacture wherein air may be drawn through aporous substance or filter mechanism of a cartridge which has beenmoistened with a chemically harmless flavoring preparation.

An additional objective of the instant system is to combine moisture andtaste wherein the moist and flavored air passes through a section of thedevice heated by a suitable heating element in order that warm, moistand flavored air is drawn into the mouth of the user, and if desired,into the lungs of the user.

A further object of the instant system is to provide a nano-vaporizationsystem for circulating the fluid around the heating element in aturbulent manner to suitably raise the temperature of the inhalantmixture, with the purpose that the temperature of the flavored air.

A further object is to insulate the heat source as the mechanism may betoo hot for the user to hold as well as to introduce a nasal adapterdevice to be utilized with instant vapor medicine delivery system, whichcan be adapted for both human and animal applications. An additionalobject is to introduce a nano-misting or nano-mist system, which can beadapted for both human and animal applications.

A further object of the instant system is to introduce an apparatus withthe capability of delivering water, menthol, eucalyptus or glycerolbeads of a micro size when compared to current vaporizers by Vicks® orother such systems which deliver large water drops that don't go deep inthe lungs. Moreover, concurrent inhalers and nebulizers do not deliverdroplets measured in nanometers.

An added and prominent objective of the instant device is to introduce aface mask to prevent transmission of disease and a filtration system toprotect against potential contamination. And, an unexpected result ofexperimentation with drug delivery processes focuses on the positiveutilization of the by-product vapor alone to clean, clear and soothe thelungs and enhance lung functions with the clean steam with smallparticle size.

An unexpected result of vaporizers is that the vapor can carrybeneficial drugs that actually treat diseases as well as administertreatments and therapies. Unlike today's existing technology which isused as a cigarette cessation or replacement product containing thecarcinogen nicotine and in no way is it used or meant to be for thebenefits, promotion of health in fact curing or pain managements herecited. You are in effect steam cleaning your lungs and thus entails awhole new entry point for these drugs into the body. Also introduced, aplain water vapor, with nothing added, from these devices, was observedto open the lungs and allow the user to breathe better.

The varied the size of vapor droplets to suit the molecule size of drugsusing the existing technology heat control can lead to immediatemigraine treatment with such drugs Sumitriptan®. It was not expectedthat existing devices can work for headaches and other pain management,such as NSAIDs for arthritis.

In additional embodiments, the system may be design to utilizepharmaceutical prescribed drugs (other not nicotine) and caffeine may behelp reduce the boiling point or volatilization of another drug. It canalso be used for energy vapor markets to replace the energy drink space.Unexpected was that these devices deposit drugs under tongue and in allmouth receptors so delivery is not only through lungs. Different thancurrent use which is intended for lung delivery.

Further addressing the nasal vaporizing as another point of entrytotally different than concurrent systems, this would be beneficial totreat many things nasally as well as another entry point to the lungsthat is not done using current tech. Also, replaces nasal spray.

Intranasal is a good area for low dose potent drugs, since surface areais normally too small. An additional route for vaccines since you needvery little to obtain an antigenic immune response. Thus the instantsystem allows the user to administer gene therapy as well as viruses andvaccines through the lungs.

Additionally, the system may be utilized for diagnostics and may deliversmall molecule drugs as deep as this into the lungs. The depth and reachof drug deposition is unique as the stomach is bypassed stomach forefficacy, purity and speed and thus the drugs or medicines areinherently purer. Thus, mixtures or cocktails can be blended. Forexample, adding caffeine for energy and to lower the vaporizing temp forother drugs that will not survive the heat.

Aromatherapy usage can clearly provide more focused attention and can bepart of our nutritional or neutraceuticals. Wine and alcohol mixed withflavors and glycol or other carriers. Any and all compounds and mixturesmay be utilized to cleanse lungs, including common menthol. Sublingual,and mouth and lung combination absorption is possible, including B12absorption. The vaped B12 will be absorbed thru the mouth and the lungsproviding extra energy to the body.

Further, nacetyl lcysteine may be vaped into the lungs and combiningthis with a nonionic surfactant like polysorbate 80 (TWEEN 80) to createthe best available compound which will also be mucolytic. Additives forinfections may also be utilized. Thus, all nutraceuticals may beemployed, again because the process is in liquid form. And a furthercombination of mucolytic drugs, cysteine and a non-ionic surfactant(TWEEN 80, poysorbate or other non-ionic surfactants can also be used.The system can therefore replace nasal spray because it delivers amicro-aerosolized dose of therapeutic medication.

Thus, the instant system to deliver drugs and other actives via variousroutes where other delivery systems have failed or require injections.The delivery system allows drugs to be vaporized (vaped) and efficientlydelivered to the lungs, through the nasal route and mouth, includingsublingual and across other mucosal membranes. The target marketincludes delivering efficiently nutraceuticals, herbals, prescriptionand non-prescription drugs including vitamins, vaccines, anti-pyretics,pain (narcotic and non-narcotic including migraine headaches), diabetes,cystic fibrosis, drugs for obesity and anti-ageing, in a vaporizedstate. Several patents have been filed to include over-the-counter (OTC)drugs, nutraceuticals, prescription drugs such as nitroglycerin,sildenafil (Viagra, and other similar drugs), active ingredients ofVicks VapoRub and recreational and lifestyle style improving drugs. Alldrugs in a solvent system that can be vaporized and are heat stableunder the E-cig temperatures are included. Vaccines can be delivered indeveloping countries in a cost-effective manner without crosscontamination by changing the disposable tip attached to the device.

Additionally, in one embodiment, the instant device will be unique formedicine as it will comprise a one-way fill valve and thus operate as aone way inhaler to prevent spread of disease if device is being shared,and HEPA® and other filters or better. The fill valve will bespring-loaded may be torsion or other such mechanism as well and whichallows the cartridge to be filled with a “needle-point” bottle. Thecartridge may be a disposable tip with a one way valve.

For the instant system, this will allow for the cartridge to be filledwith medication, while preventing the “patient” from extracting thesolution from the cartridge. A specific voltage may to be preset on thebattery device specific for each medication, along with an automaticshut-off feature preventing the solution from reaching a defined maximumtemperature.

In additional embodiments, steroids, testosterone alcohol, cortisone,prednisone may be administered. Further and even blowing it out in afine mist to cure large areas of the outside of the body. Can administerburn and many therapies or actual drugs like Botox. Furthermore, avaporizing vaccine is introduced and also the clearance of lungs due toPropylene Glycol, using Camphor in small particle emission and evenvaping of antibiotics to treat pneumonia rather quickly, and a processfor treating lung disease with herbs.

The instant system can thus transport antitussive herbs to reducerespiratory spasms; expectorant herbs loosen mucus; demulcent herbssooth irritated tissue; and antimicrobial herbs resolve infections. Fortransportation of drugs, in the instant system they may not have to befrozen as they are submerged in the VG/PG or other carrier, thus buriedand protected. Also process patents for the drugs that have never beenprocessed in this manner. The drugs are processed through the lungs, notIV, Pills, Powder inhalers, or nebulizers. The system also incorporatessublingual administration as the vapor effects all receptors of themouth.

Moreover, many processes for the treating of disease and introducingdrugs are herein illustrated, for example the system may be utilized toassist breathing for asthma patients. Further, in any of the mixture,the addition of a small quantity of water in the mix to, can preventdehydration a recurring occurrence with VG/propylene glycol non-aqueoussystems. The quantity of the water will be adjusted so that we do notget precipitation of the active. If required, additional ingredientswill be added such that the system delivers with a clear mixture or acolored mixture as required for medical or diagnosis purposes. Thus, theinstant system represents discovered a new way to improve the currentVG/PG mix and transport of all known drugs using an enveloping solutionlike PG/VG.

Further, Lavender oil, which possesses a scent with a calming effectwhich may aid in relaxation and the reduction of anxiety and stress maybe employed. Lasea capsules containing Lavender oil with a high amountof linalool and linayl acetate termed as Silexan by the manufacturer areapproved as an anxiolytic in Germany. The approval is based on thefinding that the capsules are comparable in effect to low-doselorazepam. Additionally, all of the systems herein are adaptable toveterinary use.

Moreover, the instant system may cover all parenteral and non-parenteralroutes for administering drugs. The parenteral routes includeintravenous, intramuscular, subcutaneous and intradermal. Thenon-parenteral routes include oral, sublingual, buccal, nasal andvaginal. Drugs such as Bayer®, baby aspirin, and other drugs formigraine and headache, as well as, Pfizer® Viagra® when deliveredsublingually map provide biological stability and rapid absorption ofthe drug.

Yet another object of the present system is to provide a lung cleansingtreatment that cleans and clears lungs due to its depth of reach intothe smallest airways. Lung cleansing treatment works because the size ofthe droplet created by the current system is measured in nanometers, anddroplets at this size can go to the smallest of airways in the lungs,where menthol and other ingredients inside these particles can bedelivered. The droplets are able to attach themselves to the coldreceptors in the lining of the airways, which creates shrinkage. Theskin retracts as the menthol opens the airways, creating greaterbreathing capacity. The smallest size of the droplets is key forreaching areas in hard to reach places within the lungs. Most inhaledcorticoid drug particles, due to their large size, only make it to halfof the lungs, and most of the powder stays in the throat.

It is one objective of the system to create nano-particles are thus sosmall in stature as to penetrate the alveoli, and thus proceed wherepowdered drugs are unable. The current system generates a mist that asstated is composed of tiny droplets in the low nanometer range (mentholin a gaseous state). The menthol is soothing and cooling in a gaseousstate that on inhalation reaches the deep innermost portions of thelungs.

There has thus been outlined, rather broadly, the more importantfeatures of the versatile systems, apparatuses and accompany methods inorder that the detailed description thereof that follows may be betterunderstood, and in order that the present contribution to the art may bebetter appreciated. There are additional features of the invention thatwill be described hereinafter and which will form the subject matter ofthe claims appended hereto.

In this respect, before explaining at least one embodiment of theinvention in detail, it is to be understood that the invention is notlimited in its application to the details of construction and to thearrangements of the components set forth in the following description orillustrated in the drawings. The invention is capable of otherembodiments and of being practiced and carries out in various ways.Also, it is to be understood that the phraseology and terminologyemployed herein are for the purpose of description and should not beregarded as limiting.

These, together with other objects of the invention, along with thevarious features of novelty, which characterize the invention, arepointed out with particularity in the claims annexed to and forming apart of this disclosure. For a better understanding of the interactivesystems, apparatuses and accompany methods, the operating advantages andthe specific objects attained by usage, reference should be made to theaccompanying drawings and descriptive matter in which there areillustrated preferred embodiments of the invention.

BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of thefollowing detailed description of various embodiments of the inventionin connection with the accompanying drawings, in which:

FIG. 1 illustrates a perspective view one embodiment of the vaporizingdevice illustrating the vaporization or atomization portion andelectronics portion;

FIG. 2 illustrates an exploded view of the atomizer liquid reservoir andthe main airway regions of the atomizer portion;

FIG. 3A illustrates an exploded view of the upper region of theatomization portion in a disassembled state, including the mouthpieceand the coil;

FIG. 3B illustrates an exploded view of the disassembled atomizationportion, including the liquid reservoir;

FIG. 3C illustrates an exploded view of the disassembled atomizationportion, including the main airway, the atomizer, the airflow ring andheat transfer component;

FIG. 4A illustrates the connection means between the electronics housingand the atomization portion and further comprises a heat transfercomponent of the top end of the electronics housing;

FIG. 4B illustrates the connection means between the electronics housingand the atomization portion and further comprises a heat transfercomponent of the top end of the electronics housing;

FIG. 4C illustrates the connection means between the electronics housingand the atomization portion and further comprises a heat transfercomponent of the top end of the electronics housing;

FIG. 5A illustrates an exploded view of the atomization portioncomponents including the cotton pad and main airway;

FIG. 5B illustrate an exploded view of the atomizer components includingthe metal mesh and the metal coil which is attached to the heat transfercomponent;

FIG. 6A illustrates a perspective view of an embodiment of the presentsystem utilizing a facemask for attachment to the atomization portion toform an occlusive seal with the facial surface of the user;

FIG. 6B illustrates a bottom view of an embodiment of the present systemutilizing a facemask for attachment to the atomization portion to forman occlusive seal with the facial surface of the user;

FIG. 7 illustrates a top view of the contents of the electronics housingincluding a circuit board or electronics chip, a screen, an ON button, aUSB port, a battery, and electronic connection to the heating member;

FIG. 8 illustrates a perspective view of an embodiment of the face masknasal adapter heating element, an atomizer, and a removably attachedface mask;

FIG. 9 illustrates a side view environmental view of the embodiment ofthe face mask nasal adapter of FIG. 8 illustrating the face mask in useocclusively sealed against the face of a user;

FIG. 10 illustrates a side view environmental view of an additionalembodiment of the face mask nasal adapter illustrating the face mask inuse with an additional embodiment of the delivery system wherein theface mask is occlusively sealed against the face of a user;

FIG. 11 illustrates a front perspective environmental view of anadditional embodiment of the face mask illustrating the face mask in usewith an additional embodiment of the delivery system wherein the facemask is occlusively sealed against the face of a user through the use ofa raised;

FIG. 12 illustrates a side view of the nasal adapter or face maskembodiment of FIG. 11 further illustrating the raised, arcuatelydisposed facial contact surface oriented for oral usage.

FIG. 13 illustrates a side view of the nasal adapter or face maskembodiment of FIG. 11 further illustrating the features wherein the facemask may comprise a substantially conical area and a raised, arcuatelydisposed facial contact surface.

FIG. 14 illustrates a side view of one embodiment of a cartridge to beutilized within the vaporizing system of FIG. 8, including an explodedview of the incorporated drip-tip check valve or one-way valve.

FIG. 15 is a sectional plan view of an additional embodiment of thevapor delivery system, particularly illustrating one embodiment ofcartridge which includes an absorbent sponge and an atomizer.

FIG. 16 illustrates an alternative embodiment of the vaporizing devicein which a separation means divides the atomizer an upper chamber and alower chamber for generating additional vapor.

FIG. 17 illustrates the battery charging system including the charger,the charging, the USB connector and the indicator light.

DETAILED DESCRIPTION OF THE INVENTION

The detailed description set forth below is intended as a description ofpresently preferred embodiments of the apparatus and does not representthe only forms in which the present apparatus may be construed and/orutilized. The description sets forth the functions and the sequence ofthe steps for producing the system and accompanying apparatus. However,it is to be understood that the same or equivalent functions andsequences may be accomplished by different embodiments also intended tobe encompassed within the scope of the invention.

FIG. 1 illustrates a perspective view one embodiment of the vaporizingdevice 10, which includes a vaporization or an atomization portion 15and electronics portion 14. In one embodiment, the atomization portion15 may further comprises a mouthpiece 22, liquid reservoir 16 andatomizer 28. In an additional embodiment, the electronics portion 15further comprises an outer shell 26, USB port 24, and ON Button 33. Inone embodiment, the mouthpiece 22 may comprise a top filling mouthpiece.The integrated circuit (IC) or microprocessor 27 (shown in FIG. 7)releases a signal to activate and deactivate said power source, throughthe integrated circuit (IC), in this case the microprocessor 27.

The mouthpiece 22 is under negative pressure and a quantity of airpressure thus generated releases an actuating signal to microprocessor27 to activate the power source and vapor is generated when the liquidmakes contact with the atomizer permitting air to be drawn past acartridge for inhalation by the user at the mouthpiece.

FIG. 2 illustrates an exploded view of the atomizer liquid reservoir 16and the atomizer 28. The atomization portion 14 further comprises a setof atomizer liquid inlets 13. In one embodiment, the user fills theliquid reservoir 16 with the liquid to be vaporized and liquid slowlytrickles into the atomizer 28 through the set of atomizer liquid inlets13.

FIGS. 3A-3C illustrate a set of exploded views of the disassembledatomization portion, including the mouthpiece 22, coil 34, the liquidreservoir 16, the main airway 44, and the heat transfer component 23.

FIG. 3A illustrates an explode view of the upper section of thedisassembled atomization portion, including the mouthpiece 22 and thecoil 34. A key element to the creation of the nano-mist ornano-particles focuses the utilization of high coil temperatures underdry, wet-through-wick, and full-wet conditions. Many factors, such ascoil material and resistance, battery voltage, atomizer/wick design,e-liquid composition and fill level, and vaping topography (puffingtime, interval, or volume) may affect the operating temperature ofe-cigarettes. The liquid reaches a temperature of roughly 100° C.-250°C. or greater within the atomizer 28 to create an aerosolized vapor andthe product of such conditions respectively create droplet sizes varyingfrom 50 nano-meters to 400 nano-meters.

Numerous recent studies have indicated that delivery of certainapplicable substances through nasal cavities has proved moreadvantageous than through conventional oral intake methods. In line withthese studies, the nano-particles created by the present system, due tothe high temperature vaporization, are specifically designed and suitedfor such activity in order to directly reach the bronchioles are some ofthe smallest airways in your lungs. Thus, the nano-particles are inhaledand pass through tiny ducts from the bronchioles into elastic airsacs—or alveoli.

FIG. 3B illustrates an explode view of the median section of thedisassembled atomization portion, including the liquid reservoir 16.

FIG. 3C illustrates an exploded view of the lower section of thedisassembled atomization portion, including the atomizer 28, the airflowring 47 and heat transfer component 23.

FIGS. 4A-4C illustrates the connection means between the electronicshousing 14 and the atomization portion 15. The upper portion 30 of theelectronics housing 14 further comprises a heat transfer component 23,which becomes hot by means of a battery and electric circuit boardlocated within the electronics housing 14 (seen in FIG. 7).

The bottom portion 32 of the atomization portion 15 further comprises aheating member 16, which mates to the heat transfer component 23 bymeans of threading. The heating member 16 transfers heat through theheat transfer component 23, thereby providing heat for the atomizationprocess.

FIGS. 5A and 5B illustrate an exploded view of the atomizer 28, whichfurther comprises a metal mesh 20 and cotton pad 42. Inside of theatomizer 28, there is a tank and metal coil 34, which is attached to theheat transfer component 23. The cotton pad 22 soaks up liquid, whichsecretes through the atomizer liquid inlet 13. The tank and metal coil34 contacts the soaked cotton pad 42 and vaporizes the liquid stored inthe cotton pad 42. As the user inhales, the vapor moves up through thelower airway 36, into the main airway 44, through the mouthpiece 22, andinto the user's mouth.

FIGS. 6A and 6B illustrate perspective views of a facemask 40 which maybe removably attached or permanently fixed to the atomization portion15. In one embodiment, the facemask 40 may comprise a substantiallyconical area and a compliant or flexible connector or coupling mechanismfor removable attachment to the vaporizing system. The facemask furthercomprises a raised, arcuately disposed facial contact surface 49, whichcreates an airtight, occlusive seal between the user's face and thefacemask 40.

FIG. 6A illustrates a side perspective view of an embodiment of thepresent system utilizing a facemask 40 for attachment to the atomizationportion 15 and the mouthpiece 22 to form an airtight, occlusive sealbetween the user's face and the facemask 40.

FIG. 6B illustrates a bottom view of an embodiment of the present systemutilizing a facemask 40 for attachment to the atomization portion 15 andthe mouthpiece 22 to form an occlusive seal with the facial surface ofthe user. The facemask 40 further comprises a raised, arcuately disposedfacial contact surface 49, which assists in the creation an airtight,occlusive seal between the user's face and the facemask 40.

In one embodiment, the facemask attaches to the mouthpiece 22 by meansof a compliant or flexible connector 38, which remains in place due tothe friction between the compliant or flexible connector 38 and thesurface of the mouthpiece 22. The compliant or flexible connector 38 maycontain a ringed or threaded outer portion in order to assist the userin the installation and removal of the compliant or flexible connector38.

In one embodiment, the facemask 40 may further comprise a flexible,elastomeric material, capable of retaining an airtight connection with avariety of surface textures for adaptation to differing vapor dispensingsystems as illustrated herein.

FIG. 7 illustrates a top view of the contents 42 of the electronicshousing 4. The contents 4 further comprise a microprocessor 27, screen37, ON button 33, USB port 24, battery 46, and electronic connection 48to the heating member 16. When the user presses the On button 33, theheating member 16 generates heat.

FIG. 8 illustrates a side perspective view of an additional embodimentof a vaporizing system 50 with a face mask nasal adapter. Herein, a user58 is utilizing the nasal adapter with an internal battery device andheating element 52, an atomizer 54, and a removably attached face mask56.

FIG. 9 illustrates a side view environmental view of the embodiment ofthe nasal adapter or face mask 56 illustrating the face mask 56 in useocclusively sealed against the face of a user 58.

FIG. 10 illustrates a side view environmental view of an additionalembodiment of the nasal adapter or face mask 56 illustrating the facemask 56 in use with an additional embodiment of the delivery systemwherein the face mask 56 is occlusively sealed against the face of auser 58. In operation the user 58, utilizes the face mask 56 inconjunction with a digital vaporizer system 60, wherein a digital readout electronic portion 61 and atomizer portion work in conjunction toallow the user to adjust temperature, vaporization, and other qualitiesfor a customized use depending on the substance used. When in use, auser places the face mask over his nose area, activates the atomizer,and breathes in the released vapor.

Further illustrated is the compliant or flexible connector 59 which mayinclude grip ribs or grip threads 57 for ease of attachment and removal,and the atomizer 54 utilized for this embodiment.

In a preferred embodiment, the face mask mechanism 16 provides a one-wayvalve, as illustrated in FIG. 13, which allows for a dispensing of mistand vapor that would be inhaled by the user 58. In one embodiment, thebattery device is removable so that when exhausted, a fresh dry batterymay be substituted.

FIG. 11 illustrates a front perspective environmental view of anadditional embodiment of the nasal adapter or face mask 56 illustratingthe face mask in use with an additional embodiment of the vapor deliverysystem, wherein the atomizing portion 54 of the vapor delivery system isillustrated. This perspective view more clearly illustrates how the facemask 56 matches the contour of the user face as well as the outwardextension of the nasal cavity of the user.

The face mask 56 may comprise a substantially conical area 51 and araised, arcuately disposed facial contact surface 53. In numerousembodiments, the raised, arcuately disposed facial contact surface 53may be composed of a more malleable and substantially less dense orcompliant materials than that of the conical area 51. Thus, thecompliant material of the facial contact surface 53 will provide anocclusive seal against the face of a user and the raised, arcuatelydisposed facial contact surface 53 is designed to match the contour ofarea surrounding the human nasal area to provide for minimal gappingwith the occlusive seal.

The facemask 56 may be composed of numerous applicable polymers and inone embodiment silicone may be utilized. Thus, in the manufacturingprocesses, the conical area 51 will be molded, pressed or extruded to bedenser and much less flexible than the thin, facially form fittingmaterial of the facial contact surface 53.

Furthermore, the facemask 56 may also include a compliant or flexibleconnector or coupling mechanism 59 for removable attachment to thevaporizing system 54. The facemask 40 further comprises a raised,arcuately disposed facial contact surface 49, which creates an airtight,occlusive seal between the user's face and the facemask 40.

FIG. 12 illustrates a side view of the face mask 56 of FIG. 11 furtherillustrating the features wherein the face mask 56 may comprise asubstantially conical area 51 and a raised, arcuately disposed facialcontact surface 53. In this embodiment, illustrated the raised,arcuately disposed facial contact surface oriented for oral usage.

Again the raised, arcuately disposed facial contact surface 53 may becomposed of a more malleable and substantially less dense or compliantmaterials than that of the conical area 51. Thus, the compliant materialof the facial contact surface 53 will provide an occlusive seal againstthe face of a user and the raised, arcuately disposed facial contactsurface 53 is designed to match the contour of area surrounding thehuman nasal area to provide for minimal gapping with the occlusive seal.The facemask 56 may also compliant or flexible connector or couplingmechanism 59 for removable attachment to a vaporizing system.

FIG. 13 illustrates a side view of the nasal adapter or face mask 56 ofFIG. 11 further illustrating the features wherein the face mask 56 maycomprise a substantially conical area 51 and a raised, arcuatelydisposed facial contact surface 53. Again the raised, arcuately disposedfacial contact surface 53 may be composed of a more malleable andsubstantially less dense or compliant materials than that of the conicalarea 51. Thus, the compliant material of the facial contact surface 53will provide an occlusive seal against the face of a user and theraised, arcuately disposed facial contact surface 53 is designed tomatch the contour of area surrounding the human nasal area to providefor minimal gapping with the occlusive seal. The facemask 56 may alsocompliant or flexible connector or coupling mechanism 59 for removableattachment to a vaporizing system of choice.

FIG. 14 illustrates a side view of one embodiment of a cartridge 122 tobe utilized within the vaporizing system 50 of FIG. 8, including anexploded view of the incorporated check valve or one-way valve 110. Thecartridge 122 is fully-sealed and further comprises a spring-loadedvalve 114, a fill valve 116, and an atomizer 114 located at the base ofthe cartridge with a threaded fastening mechanism 120. Also illustratedis a drip-tip with a one-way valve 110 that facilitates flow of oil ontothe vaporizing surface, which comprises a heated surface such as a coil,metal plate or other heating means.

FIG. 14 further illustrates an exploded view of the spring-loaded valve,which further comprises an inlet tract 115, disc 117, spring 119, springrod 123, and seal 121. The spring-loaded valve 114 is engaged when theuser orally creates the anterior end 172 of the vaporization device 158through the mouth piece, as shown FIG. 14. The pressure drop caused bythis sucking action causes the spring rod 123 to push up on the spring119 and release a controlled amount of liquid into the atomizer 114through the inlet tract 115.

FIG. 15 is a sectional plan view of an embodiment of the vapor deliverysystem. The system includes an outer housing 158 which includes aproximal end 172 and a distal end 160. The proximal end 172 of thehousing is design to be oriented toward the user's mouth. The distal end160 of the housing 158 is proximate to the battery 164. The cartridge174 includes an absorbent sponge 166, atomizer 14 and a liquid supplyingbottle. The proximal end 172 of the housing 158 includes the mouthpiece178 and a filter 176.

The filter 176 further comprises a means of preventing liquid fromleaving the proximal end of the housing while facilitating the diffusionof vapor into the user's mouth. The mouthpiece 178 attaches to theproximal end. When the user inhales, the mouthpiece 178 experiencesnegative pressure that activates an actuating signal to an IC switch 168to activate the power source. This system may also include a smart chipand control panel as and a lithium ion rechargeable battery 12 as apower source as shown in FIG. 1. Vapor is generated when the heatedliquid makes contact with the atomizer 14.

FIG. 16 illustrates an alternative embodiment of the vaporizing devicein which a separation means 180 divides the atomizer 14 an upper chamber182 and a lower chamber 184 for generating additional vapor. Thevaporizer further comprises a metal coil 181, which is heated tovaporize oil in the upper chamber 182 and lower chamber 184.

FIG. 17 illustrates the battery charging system 150. To charge thebattery, remove the cartridge, 122 containing the liquid. Once thecartridge has been properly removed, gently screw the cartridge into thecharger 132. With the battery attached to the charging cable 131, plugthe charging cable 131, which contains a USB end 130, into any USB slotor use a wall plug and connect it to a 110 Volt electric outlet. Thereis an indicator light 134 on the charging cable that will glow red whilecharging. Once the battery 12 is done charging, the indicator light 134will glow green.

In numerous embodiments, a cylindrical mechanism or an external tubemade preferably the size, color and form of a cigarette, such tubehaving an outer end portion and an inner end portion, subdividing theinterior space of the external tube is an internal shoulder which ispreferably closer to the outer end portion than to the opposite innerend portion, thus dividing the tube into relatively short andsubstantially longer chambers. In some embodiments, the battery deviceis removable so that when exhausted, a fresh dry battery may besubstituted.

The tube is supplied at the inner end portion with internal threads orsome other means of connection for a mouthpiece as later described. Inthe outer end portion is detachably fitted a flavor cartridge of somesuitable absorbent material, preferably having longitudinal spacedpassages there through of a small diameter. The cartridge is abuttedagainst the outer edge of the internal shoulder and is of an externaldiameter to fit snugly into the outer end portion so that it will beheld therein by friction or other suitable means.

Within the more forward chamber of the outer tube is received a tubularliner preferably of insulating material and having an internal wall of aform and character to tumble the air or create turbulence therein. Thisinternal wall may be spiraled or rifled as indicated. A mouthpiece isaffixed to the inner end portion of the tube in any appropriate manner,preferably detachably as by external threads on the hollow shank of themouthpiece which mate with the internal threads in the inner end portionof the outer tube.

The free outer end of the hollow shank, when fitted home in the outertube, will encounter and push the insert against the inner wall of theinternal shoulder thus holding the insert immovably in place.

The hollow shank will preferably have an outstanding shoulder forwardlyof the threads to engage the inner end of the tube in the completelyassembled position of the mouthpiece relatively to the outer tube.

A cross-section through the hollow shank portion of the mouthpiece, aspider formation is shown providing air draft spaces between the hollowshank and an inner ring spaced inwardly from the hollow shank andconnected therewith by radial arms. The air draft spaces communicatewith the suction orifice of the mouthpiece at the inner end and at theouter end with the space circumscribed by the inner wall of the tubularinsert.

Within the inner ring is a threaded electric socket and forwardlythereof a battery cavity for detachably receiving a battery having aninner contact and an outer contact with a contact strip between theinner contact and the socket.

The heating element is preferably a vacuum tube or bulb having a screwplug for detachable engagement with the socket. The screw plug has anend contact adapted to close against the outer battery contact. The bulbor tube, similar to a light bulb, is preferably elongated and of adiameter to fit within the insert in such manner heating passagethroughout the length of the bulb and around the complete circumferenceof the bulb in assembly, the flavor cartridge can be introduced andremoved without regard to the other units of the device.

Before the mouthpiece is assembled to the external tube, the liner isslid through the open inner end portion of the tube until the outer endof the liner encounters the internal shoulder. The bulb will be mountedto the socket while the mouthpiece is detached from the tube whereuponthe bulb may be introduced into the insert as the mouthpiece is put intoplace and rotated to effect attachment of the mouthpiece to the outertube. The final home position of the parts is indicated in which thehollow shank engages the inner end of the insert while the outer end ofthe insert is abutted against the internal shoulder.

When the bulb is assembled to the socket its tip end will engage theinner battery contact and complete the circuit through the filament ofthe bulb by the contact strip. Thus the bulb will be illuminated orenergized before assembly to the external tube.

The battery is removable so that when exhausted, a fresh dry battery maybe substituted, access to the same being had by first unscrewing themouthpiece and withdrawing the bulb and subsequently removing the bulbfrom its socket.

The insert is preferably of a ceramic material. By the act of inhalationthrough the mouthpiece, air from the ambient atmosphere is drawn inthrough the passages of the cartridge which has been impregnated withsuitable flavoring material which is picked up by the inhaled air andsuch air then passes into the heating chamber and is caused to flowaround the heating bulb, the heated and flavored air finally passingthrough the mouth piece into the mouth and also, if desired, into thelungs.

An air circulation or recirculation system may be incorporated in orderto cool the outer surface of the mechanism. The cartridge may contain adrip tip and a one-way valve to prevent the spread of disease if reused.The cartridge may be reusable or disposable, as may well be the tipmechanism.

The impregnation will be by a harmless flavored chemical compound. Assuggested, such compounds may be solutions ranging from slightlymentholated water to a solution which would simulate artificially theflavor of menthol, or other lung soothing or cleansing substance ormixture.

A list of some herbals, nutraceuticals and configuration (which do notinclude regulatory requirements) that may be administered through theinstant system include, but are not limited to the following:

1) Lung Cleansing Kits (including the active ingredients along the linesof menthol and other akin to Vics VapoRub®);2) Weight Control systems (Active ingredients of Hydroxicut®3) Sleep Aid (Melatonin, diphenhydramine and other OTC drugs);4) Anxiety, depression, relaxant (Valerian Root Extract with or withoutBay Leaf Extract);5) Energy Formulations used in HealthCare®, sold in Whole Food® stores;5) CoQ10® (High priced formulations sold in GNC®, etc.);6) Pain (Naproxen®, Ibuprofen® other NSAIDs);7) Sleep Aid (melatonin, diphenhydramine and other OTCs);8) Migraine relief nutraceuticals or herbals.

The system may further comprise variations such as the use of lavendertype extracts for the purposes of:

-   -   a. preventing panic attack and anxiety;    -   b. calming effect aids relaxation;    -   c. reducing stress; and,    -   d. relieving pain from tension headache.

Thus, herein is presented a lung cleaning system driven by utilizationof nano-particles, in conjunction with a containment system such as amask, to ensure delivery of the nano-particles. The system isillustrated by example in the figures, and throughout the writtendescription. It should be understood that numerous variations arepossible, while adhering to the inventive concept. Such variations arecontemplated as being a part of the present apparatus and set ofaccompanying systems.

It should be understood that numerous variations are possible, whileadhering to the inventive concept. Such variations are contemplated asbeing a part of the present invention.

What is claimed is:
 1. A lung cleansing system comprising: a vaporizingsystem comprising: a mouthpiece; a liquid reservoir and vaporizingliquid; a main airway; and an atomization portion wherein theatomization portion further comprises; an atomizer; a heating coil; andheat transfer component; an electronic portion comprising: an outershell; a microprocessor; a USB port; and an ON Button; and a face maskin communication with the mouthpiece.
 2. The lung cleansing system ofclaim 1 wherein the face mask further comprises a raised, arcuatelydisposed facial contact surface.
 3. The lung cleansing system of claim 1wherein the face mask comprises a compliant connector.
 4. The lungcleansing system of claim 3 wherein the compliant connector comprises aset of grip threads.
 5. The vaporized cleaning lung system of claim 1,wherein the vaporizing system further comprises a drip tip one wayvalve.
 6. The lung cleansing system of claim 1 wherein the mouthpiececomprises a top filling mouthpiece.
 7. The lung cleansing system ofclaim 1 wherein the heating element hats the liquid to a temperaturerange from 100° C.-250° C.
 8. The lung cleansing system of claim 1wherein the system heats vapor to creates nano-particles in a size rangefrom fifty nano-meters to four hundred nano-meters.
 9. The lungcleansing system of claim 1 wherein the face mask comprises a raised,arcuately disposed facial contact surface disposed to match the contourof the area surrounding the human nose to provide an occlusive seal. 10.A vaporized lung cleansing system comprising: a main body for enclosingsaid vaporized lung cleansing system, said body having an anterior endand a distal end; a cartridge, comprising an absorbent sponge; anatomizer and a liquid supplying bottle; a power source; a heatingelement within the distal end of the body for transferring heat to theliquid; a mouthpiece on the anterior end of the body for drawingatmosphere air by inhaling through the anterior end of the bodyincluding the cartridge and through the space between the heatingelement; an integrated circuit (IC) switch for releasing a signal toactivate and deactivate said power source, wherein the mouthpiece isunder negative pressure and a quantity of air pressure thus generatedreleases an actuating signal to integrated circuit (IC) to activate thepower source and vapor is generated when the liquid makes contact withthe atomizer permitting air to be drawn past a cartridge for inhalationby the user at the mouthpiece; and a removably attached face mask. 11.The vaporized lung cleansing system of claim 10 wherein the heatingelement hats the liquid to a temperature range from 100° C.-250° C. 12.The vaporized lung cleansing system of claim 10 wherein the atomizationportion heats vapor to creates nano-particles in a size range from fiftynano-meters to four hundred nano-meters.
 13. The vaporized lungcleansing system according to claim 10, wherein said atomizer includesan upper chamber and lower chamber.
 14. The vaporized lung cleansingsystem of claim 10 wherein the system delivers plain menthol to cleanselungs.
 15. The vaporized cleaning lung system of claim 10, wherein themouthpiece has a drip tip comprising a one way valve.
 16. The vaporizedcleansing lung system of claim 1 wherein the cartridge is removable. 17.A method of delivering vapor to the lungs comprising the steps of:providing a vaporized lung cleansing system having a main elongatedcylindrical body for enclosing said vaporized lung cleansing system andhaving an anterior and distal end and further comprising: a cartridge;an absorbent sponge; an atomizer; a heating element; a mouthpiece; aremovably attached face mask; a power source; an IC switch for releasinga signal to activate and deactivate the power source; and; injecting aquantity of substances into the main elongated cylindrical body;generating vapor is generated when a quantity of liquid makes contactwith the atomizer; heating the vapor to a range of 100° C.-250° C. tocreates nano-particles in a size range from fifty nano-meters to fourhundred nano-meters; routing the nano-particles through the mouthpieceby creating negative pressure and generating a quantity of air pressureto release an actuating signal to an IC switch; and routing thenani-particles from the mouthpiece to face mask.
 18. The method ofdelivering vapor to the lungs of claim 17, wherein substances areselected from the group consisting of lavender oil, caffeine, menthol,eucalyptus, glycerol beads, water, alcohol, nutraceuticals, herbals,prescription and non-prescription drugs, vitamins, vaccines,anti-pyretics, narcotic and non-narcotic pain relievers, diabetesmedications, cystic fibrosis medications, obesity medications andanti-ageing medications.